specimens is often inaccurate. In our opinion, there is insufficient evidence in the literature to mandate a definitive assessment of node numbers, both total and positive, in pelvic lymphadenectomy specimens." 4 At each body site, the adequacy of a node dissection should be based on the anatomic extent of that dissection. That extent should be chosen, in a study setting, to maximize the number of positive nodes. 5, 6 Adequacy can then be assessed by documenting surgical landmarks by intraoperative photography or even clinical notes.
For pelvic lymphadenectomies, my division has decided to rely on the gross node count when available-the node count is never increased based on microscopic examination and it is assumed that small islands of lymphoid tissue are due to fatty replacement. After gross dissection, the remaining adipose tissue is processed, and any lymphoid aggregate more than 1 mm is considered a node.
Although the policy clearly applies a double standard, it is at least a consistent standard. It will be nearly impossible to find a consensus definition of a lymph node in this setting. The anatomic purists will always demand the presence of a capsule, sinus, and germinal center. They will even order reticulin stains and step sections to demonstrate these features. Others will argue that the existence of submillimeter tumor metastases suggests that tiny unencapsulated lymphoid aggregates are the uninvolved node-like equivalent.
